Clinical Trial Update: A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the feasibility of combining clinician-directed and digital CBT with esketamine for treatment-resistant depression has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depression | Phase 1 | Status: WITHDRAWN